On 10 9, Zhengbang Technology (002157) announced a brief report on live pig sales for 2026 9. The announcement showed that Zhengbang Technology sold 84.23 ten thousand live pigs in 2026 9, down 2.95% month on month and up 6.53% year on year. Sales revenue for the month was 5.41 hundred million yuan, down 8.93% month on month and down 20.87% year on year. The average sales price of commercial pigs (excluding piglets) was 10.49 yuan/kg, down 5.79% from the previous month.
From 2026 1 to 9, the company sold a total of 810.99 ten thousand live pigs, up 41.48% year on year, and recorded cumulative sales revenue of 58.16 hundred million yuan, down 5.30% year on year. The above data are unaudited and may differ from the data disclosed in periodic reports.
Tianyancha information shows that Zhengbang Technology’s full name is Jiangxi Zhengbang Technology Co., Ltd. It was established on 1996 09 26, with registered capital of 929808.1339 ten thousand yuan. Its legal representative is Xiong Zhihua, and its registered address is the 6th floor of the office building at No. 7003 Changdong Avenue, Nanchang High-tech Industrial Development Zone, Nanchang, Jiangxi Province. Its main businesses are the production and sale of feed, live pig farming and sales, and the production and sale ofPig farmingand the production and sale of veterinary medicines.
Currently, the company’s chairman is Bao Hongxing and its board secretary is Wang Kun. The latest annual report shows that the company has 7440 employees. Its actual controllers are Bao Hongxing, Hua Tao, and Bao Huayue (their respective shareholdings in Jiangxi Zhengbang Technology Co., Ltd.: 6.69%, 3.17%, and 0%).
The company has equity interests in or controls 67 companies, including Yunnan Lingxiu Biological Feed Co., Ltd., Jiangxi Guanglian Biotechnology Co., Ltd., and Zhengbang (Hong Kong) Trading Co., Ltd.
In terms of performance, the company’s operating revenue in 2023, 2024, and 2025 was 69.92 billion, 88.70 billion, and 147.95 billion, respectively, representing year-on-year growth of -51.50%, 26.86%, and 66.80%, respectively. Net profit attributable to shareholders was 85.29 billion, 2.16 billion, and -5.46 billion, respectively, representing year-on-year growth of 163.72%, -97.46%, and -352.51%, respectively. During the same period, the company’s asset-liability ratios were 53.97%, 46.42%, and 50.11%, respectively.
Regarding risks, information from Tianyancha shows that the company has 3702 Tianyan risks of its own, 9999 surrounding Tianyan risks, 624 historical Tianyan risks, and 878 Tianyan risk alerts.